Cargando…

Natural history of Acinetobacter baumannii infection in mice

In 2017, the WHO identified Acinetobacter baumannii as the top priority for the development of new antibiotics. Despite the need for new antibiotics, there remains a lack of well validated preclinical tools for A. baumannii. Here, we characterize and validate a mouse model for A. baumannii translati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luna, Brian M., Yan, Jun, Reyna, Zeferino, Moon, Eugene, Nielsen, Travis B., Reza, Hernan, Lu, Peggy, Bonomo, Robert, Louie, Arnold, Drusano, George, Bulitta, Jürgen, She, Rosemary, Spellberg, Brad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6638954/ https://www.ncbi.nlm.nih.gov/pubmed/31318907 http://dx.doi.org/10.1371/journal.pone.0219824

Ejemplares similares

Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii
por: Cheng, Jiaqi, et al.
Publicado: (2021)

971. The Role of Inflammation and Innate Effectors in Passive Immunization for Acinetobacter baumannii Infections
por: Nielsen, Travis B, et al.
Publicado: (2019)

Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts In Vivo Outcomes in Galleria mellonella
por: Miller, Sarah, et al.
Publicado: (2022)

In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
por: Lee, Bosul, et al.
Publicado: (2021)

Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies
por: Nielsen, Travis B., et al.
Publicado: (2015)

Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut Microbiome
por: Maeusli, Marlène, et al.
Publicado: (2020)

Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1
por: Luna, Brian M., et al.
Publicado: (2017)

Capsule carbohydrate structure determines virulence in Acinetobacter baumannii
por: Talyansky, Yuli, et al.
Publicado: (2021)

Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection
por: Luo, Guanpingshen, et al.
Publicado: (2012)

Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates
por: Lu, Peggy, et al.
Publicado: (2023)

A Nutrient-limited Screen Unmasks Rifabutin Hyperactivity for XDR Acinetobacter baumannii
por: Luna, B., et al.
Publicado: (2020)

Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis
por: Lin, Lin, et al.
Publicado: (2012)

Transcriptome Remodeling of Acinetobacter baumannii during Infection and Treatment
por: Wright, Meredith S., et al.
Publicado: (2017)

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
por: Stracquadanio, Stefano, et al.
Publicado: (2022)

Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens
por: Cheah, Soon-Ee, et al.
Publicado: (2016)

Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
por: Ramirez, Maria Soledad, et al.
Publicado: (2020)

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections with Ceftazidime-Avibactam
por: Rahmati, Elham, et al.
Publicado: (2017)

Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
por: Wright, Meredith S., et al.
Publicado: (2016)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

Acinetobacter baumannii response to cefiderocol challenge in human urine
por: Nishimura, Brent, et al.
Publicado: (2022)

Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
por: Bulitta, Jürgen B., et al.
Publicado: (2019)

Pharmacology, Dosing, and Side Effects of Rifabutin as a Possible Therapy for Antibiotic-Resistant Acinetobacter Infections
por: Phillips, Matthew C, et al.
Publicado: (2020)

Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections
por: Watkins, Richard R, et al.
Publicado: (2023)

International Clones of High Risk of Acinetobacter Baumannii—Definitions, History, Properties and Perspectives
por: Shelenkov, Andrey, et al.
Publicado: (2023)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Acinetobacter baumannii—The New MRSA?
por: Barrie, Alasdair, et al.
Publicado: (2016)

Glycosphingolipids Recognized by Acinetobacter baumannii
por: Madar Johansson, Miralda, et al.
Publicado: (2020)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

Acacia Fiber Protects the Gut from Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Colonization Enabled by Antibiotics
por: Maeusli, Marlène, et al.
Publicado: (2022)

Cryo-Electron Microscopy Structure of an Acinetobacter baumannii Multidrug Efflux Pump
por: Su, Chih-Chia, et al.
Publicado: (2019)

Antibiotic Resistance and Genotypes of Nosocomial Strains of Acinetobacter baumannii in Kazakhstan
por: Lavrinenko, Alyona, et al.
Publicado: (2021)

Interaction of Acinetobacter baumannii with Human Serum Albumin: Does the Host Determine the Outcome?
por: Pimentel, Camila, et al.
Publicado: (2021)

The Iron Content of Human Serum Albumin Modulates the Susceptibility of Acinetobacter baumannii to Cefiderocol
por: Escalante, Jenny, et al.
Publicado: (2023)

Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
por: Powers, Rachel A., et al.
Publicado: (2014)

Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates
por: Cedano, Jose, et al.
Publicado: (2022)

Identification and Characterization of an RRM-Containing, RNA Binding Protein in Acinetobacter baumannii
por: Ciani, Caterina, et al.
Publicado: (2022)

636. Genome Epidemiology of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in the United States
por: Iovleva, Alina, et al.
Publicado: (2019)

Multidrug-resistant Acinetobacter baumannii, Russia
por: Naas, Thierry, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5721ao0buac4u3ti1djvn07s9c